Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Expert Reflects on Rapidly Evolving Field of MCL

Caroline Seymour
Published: Thursday, Aug 15, 2019

Simon Rule, MD, PhD, a professor of hematology at Plymouth University Medical School

Simon Rule, MD, PhD

Frontline and second-line treatment for patients with mantle cell lymphoma (MCL) are fairly well established, but the emergence of novel agents and the potential for CAR T-cell therapy may lead to a new and perhaps chemotherapy-free paradigm, said Simon Rule, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication